|
Dr. Lalchandani Labs Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
5.58 Cr.
|
P/BV
|
0.56
|
Book Value (Rs.)
|
22.98
|
|
52 Week High/Low (Rs.)
|
29/10
|
FV/ML
|
10/4000
|
P/E(X)
|
13.39
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.96
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.96 | 1.43 | -3.61 | 2.15 | 2.33 |
| Diluted EPS (Rs.) | 0.96 | 1.43 | -3.61 | 2.15 | 2.33 |
| Cash EPS (Rs.) | 2.27 | 2.87 | -2.08 | 3.51 | 3.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.98 | 21.98 | 20.56 | 24.16 | 22.01 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.98 | 22.02 | 20.59 | 24.20 | 22.04 |
| Revenue From Operations / Share (Rs.) | 10.28 | 11.10 | 11.63 | 26.03 | 22.57 |
| PBDIT / Share (Rs.) | 2.15 | 1.00 | 0.20 | 5.55 | 5.12 |
| PBIT / Share (Rs.) | 0.84 | -0.43 | -1.33 | 4.20 | 3.93 |
| PBT / Share (Rs.) | 0.92 | 1.43 | -3.61 | 2.97 | 3.18 |
| Net Profit / Share (Rs.) | 0.96 | 1.43 | -3.61 | 2.15 | 2.33 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 20.89 | 9.04 | 1.75 | 21.33 | 22.68 |
| PBIT Margin (%) | 8.22 | -3.93 | -11.40 | 16.12 | 17.41 |
| PBT Margin (%) | 9.03 | 12.83 | -31.00 | 11.41 | 14.08 |
| Net Profit Margin (%) | 9.36 | 12.83 | -31.00 | 8.27 | 10.34 |
| Return on Networth / Equity (%) | 4.18 | 6.48 | -17.54 | 8.91 | 10.60 |
| Return on Capital Employeed (%) | 3.63 | -1.89 | -4.63 | 13.71 | 13.81 |
| Return On Assets (%) | 2.64 | 4.11 | -8.82 | 5.14 | 6.65 |
| Long Term Debt / Equity (X) | 0.00 | 0.02 | 0.37 | 0.25 | 0.27 |
| Total Debt / Equity (X) | 0.40 | 0.35 | 0.52 | 0.38 | 0.35 |
| Asset Turnover Ratio (%) | 0.28 | 0.29 | 0.28 | 0.67 | 0.72 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.92 | 1.88 | 2.07 | 2.22 | 2.98 |
| Quick Ratio (X) | 1.69 | 1.60 | 1.78 | 1.90 | 2.75 |
| Inventory Turnover Ratio (X) | 0.70 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 10.90 | 1.13 | 0.08 | 4.52 | 6.81 |
| Interest Coverage Ratio (Post Tax) (%) | 4.46 | -0.49 | -0.58 | 2.75 | 4.10 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 5.20 | 7.92 | 13.89 | 14.81 | 6.53 |
| EV / Net Operating Revenue (X) | 1.17 | 1.65 | 2.76 | 1.31 | 0.66 |
| EV / EBITDA (X) | 5.59 | 18.19 | 157.32 | 6.15 | 2.94 |
| MarketCap / Net Operating Revenue (X) | 0.99 | 1.42 | 2.44 | 1.27 | 0.61 |
| Price / BV (X) | 0.44 | 0.71 | 1.38 | 1.37 | 0.63 |
| Price / Net Operating Revenue (X) | 0.99 | 1.42 | 2.44 | 1.27 | 0.61 |
| EarningsYield | 0.09 | 0.09 | -0.12 | 0.06 | 0.16 |
